AAFC loans $5M to Bioniche vaccine scale-up facility

Guest Contributor
January 21, 2008

Bioniche Life Sciences Inc has received another funding commitment as part of its planned $100-million project to create an Animal Health and Food Safety Vaccine Manufacturing Centre at its headquarters in Belleville ON. The latest financial assistance is a $5-million repayable loan from the new Agri-Opportunities Program at Agriculture and Agri-Food Canada. The funding will be used to build a $25-million scale-up facility to produce Bioniche's E.coli O157:H7 vaccine for cattle. The firm has also received $10 million from the Ontario Ministry of Economic Development and Trade and is currently seeking the remaining $10 million from other sources. E.coli O157:H7 — the world's first vaccine to reduce the amount of E.coli O157:H7 organism shed by cattle — will be the first vaccine product produced at the scale-up facility....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.